Ketorolac Tromethamine Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ketorolac Tromethamine Injection (injection) from Gland Pharma Limited with status No longer listed by FDA. The shortage was first posted on Mar 23, 2018. Reported reason: Demand increase for the drug
Shortage details
- Status
- No longer listed by FDA
- Company
- Gland Pharma Limited
- Package NDC
- 70860-701-04
- Dosage Form
- Injection
- Presentation
- Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 70860-701-04)
- Initial Posting
- Mar 23, 2018
Reason
Demand increase for the drug